BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

287 related articles for article (PubMed ID: 18541139)

  • 1. Pioglitazone induces lipid accumulation in the rat heart despite concomitant reduction in plasma free fatty acid availability.
    Baranowski M; Blachnio-Zabielska A; Zabielski P; Gorski J
    Arch Biochem Biophys; 2008 Sep; 477(1):86-91. PubMed ID: 18541139
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Peroxisome proliferator-activated receptor alpha activation induces unfavourable changes in fatty acid composition of myocardial phospholipids.
    Baranowski M; Blachnio-Zabielska A; Gorski J
    J Physiol Pharmacol; 2009 Jun; 60(2):13-20. PubMed ID: 19617640
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pioglitazone induces de novo ceramide synthesis in the rat heart.
    Baranowski M; Blachnio A; Zabielski P; Gorski J
    Prostaglandins Other Lipid Mediat; 2007 Feb; 83(1-2):99-111. PubMed ID: 17259076
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Chronic, in vivo, PPARalpha activation prevents lipid overload in rat liver induced by high fat feeding.
    Wierzbicki M; Chabowski A; Zendzian-Piotrowska M; Harasim E; Górski J
    Adv Med Sci; 2009; 54(1):59-65. PubMed ID: 19403437
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of cevoglitazar, a dual PPARalpha/gamma agonist, on ectopic fat deposition in fatty Zucker rats.
    Laurent D; Gounarides JS; Gao J; Boettcher BR
    Diabetes Obes Metab; 2009 Jun; 11(6):632-6. PubMed ID: 19175377
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pioglitazone can ameliorate insulin resistance in low-dose streptozotocin and high sucrose-fat diet induced obese rats.
    Ding SY; Shen ZF; Chen YT; Sun SJ; Liu Q; Xie MZ
    Acta Pharmacol Sin; 2005 May; 26(5):575-80. PubMed ID: 15842776
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tissue-specific effects of rosiglitazone and exercise in the treatment of lipid-induced insulin resistance.
    Lessard SJ; Rivas DA; Chen ZP; Bonen A; Febbraio MA; Reeder DW; Kemp BE; Yaspelkis BB; Hawley JA
    Diabetes; 2007 Jul; 56(7):1856-64. PubMed ID: 17440174
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Metabolic action of peroxisome proliferator-activated receptor gamma agonism in rats with exogenous hypercorticosteronemia.
    Berthiaume M; Laplante M; Tchernof A; Deshaies Y
    Int J Obes (Lond); 2007 Nov; 31(11):1660-70. PubMed ID: 17579631
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of pioglitazone and high-fat diet on ceramide metabolism in rat skeletal muscles.
    Zendzian-Piotrowska M; Baranowski M; Zabielski P; Górski J
    J Physiol Pharmacol; 2006 Nov; 57 Suppl 10():101-14. PubMed ID: 17242494
    [TBL] [Abstract][Full Text] [Related]  

  • 10. PPARgamma agonist induced cardiac enlargement is associated with reduced fatty acid and increased glucose utilization in myocardium of Wistar rats.
    Edgley AJ; Thalén PG; Dahllöf B; Lanne B; Ljung B; Oakes ND
    Eur J Pharmacol; 2006 May; 538(1-3):195-206. PubMed ID: 16674938
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The direct antioxidative and anti-inflammatory effects of peroxisome proliferator-activated receptors ligands are associated with the inhibition of angiotensin converting enzyme expression in streptozotocin-induced diabetic rat aorta.
    Toba H; Miki S; Shimizu T; Yoshimura A; Inoue R; Sawai N; Tsukamoto R; Murakami M; Morita Y; Nakayama Y; Kobara M; Nakata T
    Eur J Pharmacol; 2006 Nov; 549(1-3):124-32. PubMed ID: 16979161
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Partial A1 adenosine receptor agonist regulates cardiac substrate utilization in insulin-resistant rats in vivo.
    Shearer J; Severson DL; Su L; Belardinelli L; Dhalla AK
    J Pharmacol Exp Ther; 2009 Jan; 328(1):306-11. PubMed ID: 18952888
    [TBL] [Abstract][Full Text] [Related]  

  • 13. S26948, a new specific peroxisome proliferator activated receptor gamma modulator improved in vivo hepatic insulin sensitivity in 48 h lipid infused rats.
    Sohn KA; Cruciani-Guglielmacci C; Kassis N; Clément L; Ouali F; Caüzac M; Lebègue N; Berthelot P; Caignard DH; Pégorier JP; Renard P; Dacquet C; Ktorza A; Magnan C;
    Eur J Pharmacol; 2009 Apr; 608(1-3):104-11. PubMed ID: 19250932
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of nutritional vitamin A deficiency on lipid metabolism in the rat heart: Its relation to PPAR gene expression.
    Vega VA; Anzulovich AC; Varas SM; Bonomi MR; Giménez MS; Oliveros LB
    Nutrition; 2009; 25(7-8):828-38. PubMed ID: 19342198
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Thiazolidinediones enhance skeletal muscle triacylglycerol synthesis while protecting against fatty acid-induced inflammation and insulin resistance.
    Todd MK; Watt MJ; Le J; Hevener AL; Turcotte LP
    Am J Physiol Endocrinol Metab; 2007 Feb; 292(2):E485-93. PubMed ID: 17003244
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Change of glucose transporter 4 and its influence on glucose and fatty-acid metabolism in type 2 diabetic myocardium].
    Wen ZY; Wu Y; Li Y; Chen XL; Wang T; Ouyang JP; Li GS
    Zhonghua Yi Xue Za Zhi; 2005 Jun; 85(21):1460-3. PubMed ID: 16061022
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Differential effects of in vivo PPAR alpha and gamma activation on fatty acid transport proteins expression and lipid content in rat liver.
    Wierzbicki M; Chabowski A; Zendzian-Piotrowska M; Gorski J
    J Physiol Pharmacol; 2009 Mar; 60(1):99-106. PubMed ID: 19439812
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Berberine improves free-fatty-acid-induced insulin resistance in L6 myotubes through inhibiting peroxisome proliferator-activated receptor gamma and fatty acid transferase expressions.
    Chen Y; Li Y; Wang Y; Wen Y; Sun C
    Metabolism; 2009 Dec; 58(12):1694-702. PubMed ID: 19767038
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Salacia oblonga root improves cardiac lipid metabolism in Zucker diabetic fatty rats: modulation of cardiac PPAR-alpha-mediated transcription of fatty acid metabolic genes.
    Huang TH; Yang Q; Harada M; Uberai J; Radford J; Li GQ; Yamahara J; Roufogalis BD; Li Y
    Toxicol Appl Pharmacol; 2006 Jan; 210(1-2):78-85. PubMed ID: 16129467
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A comparison of glycemic control, water retention, and musculoskeletal effects of balaglitazone and pioglitazone in diet-induced obese rats.
    Henriksen K; Byrjalsen I; Nielsen RH; Madsen AN; Larsen LK; Christiansen C; Beck-Nielsen H; Karsdal MA
    Eur J Pharmacol; 2009 Aug; 616(1-3):340-5. PubMed ID: 19595686
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.